ID22978A - Antagonis reseptor endotelin - Google Patents

Antagonis reseptor endotelin

Info

Publication number
ID22978A
ID22978A IDW991588A ID991588A ID22978A ID 22978 A ID22978 A ID 22978A ID W991588 A IDW991588 A ID W991588A ID 991588 A ID991588 A ID 991588A ID 22978 A ID22978 A ID 22978A
Authority
ID
Indonesia
Prior art keywords
endotelin
receptor antagonists
antagonists
receptor
endotelin receptor
Prior art date
Application number
IDW991588A
Other languages
English (en)
Inventor
Dieter Dorsch
Mathias Osswald
Werner Mederski
Claudia Wilm
Maria Christadler
Claus Jochen Schmitges
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ID22978A publication Critical patent/ID22978A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/14Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/12Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IDW991588A 1997-07-23 1999-04-22 Antagonis reseptor endotelin ID22978A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19731571A DE19731571A1 (de) 1997-07-23 1997-07-23 Endothelin-Rezeptor-Antagonisten

Publications (1)

Publication Number Publication Date
ID22978A true ID22978A (id) 1999-12-23

Family

ID=7836588

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991588A ID22978A (id) 1997-07-23 1999-04-22 Antagonis reseptor endotelin

Country Status (18)

Country Link
US (1) US6197800B1 (id)
EP (1) EP1000044A1 (id)
JP (1) JP2001510836A (id)
KR (1) KR20010022004A (id)
CN (1) CN1265102A (id)
AR (1) AR010933A1 (id)
AU (1) AU733338B2 (id)
BR (1) BR9811537A (id)
CA (1) CA2297315A1 (id)
DE (1) DE19731571A1 (id)
HU (1) HUP0003335A2 (id)
ID (1) ID22978A (id)
NO (1) NO20000324D0 (id)
PL (1) PL338070A1 (id)
SK (1) SK512000A3 (id)
TW (1) TW461887B (id)
WO (1) WO1999005132A1 (id)
ZA (1) ZA986551B (id)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben
DE10155076A1 (de) * 2001-11-09 2003-05-22 Merck Patent Gmbh Verwendung von Endothelin-Rezeptor-Antagonisten zur Behandlung von Tumorerkrankungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU693110B2 (en) * 1993-08-19 1998-06-25 Warner-Lambert Company Substituted 2(5H)furanone, 2(5H)thiophenone and 2(5H)pyrrolone derivatives, their preparation and their use as endothelin antagonists
DE19509950A1 (de) * 1995-03-18 1996-09-19 Merck Patent Gmbh Endothelin-Rezeptor-Antagonisten
DE19607096A1 (de) * 1996-02-24 1997-08-28 Merck Patent Gmbh Endothelin-Rezeptor-Antagonisten

Also Published As

Publication number Publication date
BR9811537A (pt) 2000-08-29
CA2297315A1 (en) 1999-02-04
US6197800B1 (en) 2001-03-06
CN1265102A (zh) 2000-08-30
DE19731571A1 (de) 1999-01-28
ZA986551B (en) 1999-09-20
PL338070A1 (en) 2000-09-25
HUP0003335A2 (hu) 2001-07-30
JP2001510836A (ja) 2001-08-07
AU733338B2 (en) 2001-05-10
EP1000044A1 (de) 2000-05-17
SK512000A3 (en) 2000-07-11
NO20000324L (no) 2000-01-21
NO20000324D0 (no) 2000-01-21
TW461887B (en) 2001-11-01
KR20010022004A (ko) 2001-03-15
WO1999005132A1 (de) 1999-02-04
AU8802298A (en) 1999-02-16
AR010933A1 (es) 2000-07-12

Similar Documents

Publication Publication Date Title
ID19623A (id) Antagonis reseptor vitronektin
DE69812096T2 (de) Neuropeptid y rezeptorantagonisten
DK1009732T3 (da) 1-Amino-alkylcyclohexan NMDA receptor antagonister
ATE315035T1 (de) Ccr-3-rezeptor-antagonisten
NO972016D0 (no) Indolyl-Y-reseptorantagonister
ID16742A (id) Antagonis reseptor endotelin
DE69921351D1 (de) 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii
NO993586L (no) K-8 reseptor antagonister
NO20001100D0 (no) IL-8 reseptorantagonister
NO993350D0 (no) Vitronectin-reseptor-antagonister
ID24726A (id) Antagonis-antagonis reseptor trombin
ID26223A (id) Antagonis reseptor vitronektin
ID24162A (id) Antagonis-antagonis reseptor vitronektin
DK0906294T3 (da) Benzoxazinon-dopamin D4-receptor-antagonister
ID22838A (id) Oksazolidina sebagai antagonis 5-ht2a
ATE381330T1 (de) Il-8 rezeptor-antagonisten
ID28811A (id) Antagonis reseptor vitronektin
ID24468A (id) 2-asilaminopropanamina sebagai antagonis reseptor tachykinin
DE69831413T2 (de) Il-8 rezeptor antagonisten
DE69824837D1 (de) Il-8-rezeptor-antagonisten
ID24309A (id) 2-asilaminopropanamina sebagai antagonis reseptor tachykinin
ID22978A (id) Antagonis reseptor endotelin
DE69830671D1 (de) Integrin-rezeptor-antagonisten
DK0964867T3 (da) Tachykininantagonister
TR199601082A3 (tr) Entegrin reseptör antagonistleri.